Finally, we found that SIS3, a specific inhibitor of Smad3, enhanced the effects of PLK1 inhibitor on the growth, apoptosis, and cell cycle in HCC cells carrying TERT mutation in low concentration. This evidence concerns the gene SMAD3 and hepatocellular carcinoma.